Antivirals Market to 2016 Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

C-Rad AB (Symbol:CRAD B) SWOT Analysis, Strategy, Revenues and Profits

C-Rad AB (Symbol:CRAD B) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. C-Rad AB SWOT Analysis report provides you a strategic analysis and ...

Industries: Therapy | Countries: China, Netherlands, Sweden, Spain, Poland, Greece, France, Belgium, Austria, Thailand, Taiwan, South Korea, India, Europe

Chiesi Farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chiesi Farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • November 2014
  • 66 pages

Summary Chiesi Farmaceutici SpA (Chiesi) is a research focused pharmaceutical company. The company researches, develops and distributes pharmaceutical products with particular focus on respiratory, cardiovascular, and rare diseases. Its products include Atimos, Bramitob, Clenil, Curosurf, Foster, Iperten, ...

Industries: Therapy | Countries: World, Italy, Europe, United Kingdom, North America, United States, Czech Republic, France

 Nasal Congestion-API Insights, 2014

Nasal Congestion-API Insights, 2014

  • $ 1 250
  • Industry report
  • by Delve Insight
  • November 2014

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the ...

Industries: Therapy | Countries: United States, World, India, China, Asia, North America, Singapore, Europe, Canada, Japan

EU5 Compression Therapy Market Outlook to 2020

EU5 Compression Therapy Market Outlook to 2020

  • $ 3 000
  • Industry report
  • by Global Data
  • October 2014
  • 273 pages

EU5 Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "EU5 Compression Therapy Market Outlook to 2020", provides key market data on the EU5 Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) ...

Industries: Therapy | Countries: France, Germany, Italy, United Kingdom, Spain, Europe

A Competitive Analysis of the Global Asthma and COPD Therapeutics Market : Novel Inhaler Devices and Formulations are Impetuses for Growth

A Competitive Analysis of the Global Asthma and COPD Therapeutics Market : Novel Inhaler Devices and Formulations are Impetuses for Growth

  • $ 5 000
  • Industry report
  • by Frost & Sullivan
  • October 2014
  • 69 pages

Key Findings •Chronic obstructive pulmonary disorder (COPD) is the third leading cause of death in the United States, and is in fourth place in Europe and the rest of the world. •An estimated xxmillion people are affected by COPD globally. By 2020, COPD is projected to be the third leading cause ...

Industries: Therapy | Countries: World, United States, Europe, Australia, United Kingdom, Iceland, Denmark, Japan

Respiratory Therapy News OCTOBER 2014

Respiratory Therapy News OCTOBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • October 2014
  • 28 pages

Industry Trend Analysis - Respiratory Market Stratification Inevitable, Augmented By ERS Revelations Industry Trend Analysis - Teva Follows De-Diversification Trend With Focus On CNS/Respiratory Industry Trend Analysis - Race For First US IPF Treatment Is A Dead Heat Industry Brief - Novavax Initiates ...

Industries: Therapy | Countries: United States, Greece, Germany, Japan, Europe, World, Asia

Physiotherapy Equipment Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications (Pediatric, Musculoskeletal) & by End Users (Hospitals), Advanced technologies - Global Forecast to 2019

Physiotherapy Equipment Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications (Pediatric, Musculoskeletal) & by End Users (Hospitals), Advanced technologies - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • September 2014
  • 168 pages

Developing markets such as Middle East, Australia, New Zealand, China, India, and Malaysia are lucrative markets for physiotherapy equipment, owing to favorable government incentives and developing healthcare infrastructure. The report segments the global physiotherapy equipment market by product, application, ...

Industries: Therapy | Countries: World, North America, Europe, Germany, Canada, United States, China, Australia

Physician Views: Lessons from ERS on the LABA/LAMA and triple-combination opportunities in COPD

Physician Views: Lessons from ERS on the LABA/LAMA and triple-combination opportunities in COPD

  • $ 645
  • Industry report
  • by Firstword Pharma
  • September 2014

With the opportunity for LABA/LAMA and LABA/LAMA/ICS combination therapies seen as critical in expanding the size of the COPD market, a number of presentations at this week's European Respiratory Society (ERS) congress will have been assessed with interest. Novartis disclosed, for example, that its ...

Industries: Therapy | Countries: France, Europe

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 4 995
  • Industry report
  • by GBI Research
  • July 2014
  • 72 pages

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to ...

Industries: Therapy | Countries: France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World

MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 60 pages

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 - 40% and is region/climate dependent. For those patients failing to respond to symptomatic treatments ...

Industries: Therapy | Countries: Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.